HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on cardiac care solutions, has announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health. This partnership expands the company’s launch footprint into Southern California and completes its initial targeted markets alongside New York metro, Dallas, and South Florida as it advances commercialization of its cable-free 3D ECG technology for remote cardiac monitoring and preventive cardiology.
The agreement marks a significant step for HeartBeam as it rolls out its innovative 3D ECG technology, which is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. The company’s platform technology is the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This allows physicians to identify cardiac health trends and acute conditions and direct patients to the appropriate care outside of a medical facility, potentially redefining the future of cardiac health management.
The timing of this expansion is notable given the recent regulatory milestones achieved by HeartBeam. The company’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-lead ECG synthesis software received clearance in December 2025. With over 20 issued patents related to technology enablement, HeartBeam is positioning itself as a leader in remote cardiac monitoring and preventive cardiology.
For the concierge cardiology sector, this technology offers a powerful tool for managing high-risk patients. Concierge practices like Atelier Health, which provide personalized and accessible care, can leverage HeartBeam’s cable-free device to monitor patients remotely, potentially reducing hospital visits and enabling early intervention. The impact on patients could be substantial, offering peace of mind and convenience while ensuring continuous cardiac surveillance.
The expansion into Southern California is particularly strategic given the region’s concentration of affluent, health-conscious individuals who often seek premium medical services. Atelier Health’s Beverly Hills location places HeartBeam’s technology at the center of a high-demand market for advanced cardiac care. This move completes the company’s initial targeted markets, which include the New York metro area, Dallas, and South Florida, suggesting a focused rollout strategy aimed at establishing a strong presence in key urban centers.
For the broader healthcare industry, this announcement underscores the growing trend toward remote patient monitoring and the integration of advanced diagnostics into everyday care. As cardiovascular disease remains the leading cause of death globally, innovations like HeartBeam’s 3D ECG could improve outcomes by enabling earlier detection and more proactive management of cardiac conditions. The company’s technology also aligns with the shift toward value-based care, where remote monitoring can reduce costs and improve patient satisfaction.
Investors and industry observers will be watching closely as HeartBeam continues to execute its commercialization strategy. The company’s newsroom provides updates on its progress, and further details on the cleared indications for use can be found on the company’s website. For more information about HeartBeam and its technology, visit https://ibn.fm/BEAT.
